GREGORY T SEYMOUR MD
NPI 1720041056
Internal Medicine - Hematology & Oncology in Kingwood, TX
NPI Status: Active since April 08, 2006
Contact Information
22710 PROFESSIONAL DR
KINGWOOD, TX
ZIP 77339
Phone: (281) 298-8444
Fax: (281) 298-7720
- Individual
- Male
- Internal Medicine
- Hematology & Oncology
- Accepts Insurance
- PECOS Enrolled
- Medicare Quality Reporting
About GREGORY SEYMOUR
This page provides the complete NPI Profile along with additional information for Gregory Seymour, an internist established in Kingwood, Texas with a medical specialization in Internal Medicine, focusing in hematology & oncology . The healthcare provider is registered in the NPI registry with number 1720041056 assigned on April 2006. The practitioner's primary taxonomy code is 207RH0003X with license number K9663 (TX). The provider is registered as an individual and his NPI record was last updated 9 years ago.
- NPI
- 1720041056
- Provider Name
- GREGORY T SEYMOUR MD
- Gender
- Male
- Entity Type
- Individual
- Location Address
- 22710 PROFESSIONAL DR KINGWOOD, TX 77339
- Location Phone
- (281) 298-8444
- Location Fax
- (281) 298-7720
- Mailing Address
- 22710 PROFESSIONAL DRIVE KINGWOOD, TX 77339
- Mailing Phone
- (281) 312-8560
- Mailing Fax
- (281) 298-7720
- Is Sole Proprietor?
- No
- Enumeration Date
- 04-08-2006
- Last Update Date
- 06-06-2016
- Code Navigator
An internist like Gregory Seymour is a physician who has completed an internal medicine residency and is board-certified or board-eligible in an internist specialty. Internists are trained to care for adults of all ages for many different medical conditions. An internist typically monitors chronic physical conditions, identifies acute diseases, provides family planning, provides counseling about wellness and disease prevention, etc.
Location Map
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Internal Medicine Hematology & Oncology
- Taxonomy Code
- 207RH0003X
- Type
- Allopathic & Osteopathic Physicians
- License No.
- K9663
- License State
- TX
- Taxonomy Description
- An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.
Insurance Plans Accepted
According to publicly available information the provider might be accepting the following health plans from these health insurance companies:
- Blue Advantage Bronze HMO? 204 - HMO
- Blue Advantage Bronze HMO? 301 - HMO
- Blue Advantage Bronze HMO? Standard - HMO
- Blue Advantage Gold HMO? 206 - HMO
- Blue Advantage Gold HMO? 603 - HMO
- Blue Advantage Gold HMO? Standard - HMO
- Blue Advantage Plus Bronze? 303 - POS
- Blue Advantage Plus Bronze? 305 - POS
- Blue Advantage Plus Bronze? Standard - POS
- Blue Advantage Plus Gold? 203 - POS
- Blue Advantage Plus Gold? 803 - POS
- Blue Advantage Plus Gold? Standard - POS
- Blue Advantage Plus Silver? 202 - POS
- Blue Advantage Plus Silver? 605 - POS
- Blue Advantage Plus Silver? Standard - POS
- Blue Advantage Security HMO? 200 - HMO
- Blue Advantage Silver HMO? 205 - HMO
- Blue Advantage Silver HMO? 801 - HMO
- Blue Advantage Silver HMO? Standard - HMO
Specific plan information not avaialable, please contact the provider to verify if your insurance plan is accepted.
Specific plan information not avaialable, please contact the provider to verify if your insurance plan is accepted.
*Please verify directly with this provider to make sure your insurance plan is currently accepted.
Additional Identifiers
The NPI Enumerator encourages providers to submit additional identifiers with their NPI application although the submission of this information is optional. The additional identifier(s) section includes other numbers or codes currently or formerly used as an identifier for the provider by other public healthcare entities. The identifiers may include UPIN, NSC, OSCAR, DEA, Medicaid State or PIN identification numbers.
| Identifier | Type / Code | Identifier State | Identifier Issuer |
|---|---|---|---|
| 8A0729 | MEDICARE ID-TYPE UNSPECIFIED (04) | TX | |
| H50615 | MEDICARE UPIN (02) | ||
| 147289602 | MEDICAID (05) | TX | |
| P00074657 | MEDICARE PIN (08) | TX |
Medicare Participation & PECOS Enrollment Status
Gregory Seymour is enrolled in PECOS and is eligible to order or refer health care services for Medicare patients. The provider is eligible to order or refer: Part B Clinical Laboratory and Imaging, Durable Medical Equipment (DME), a Home Health Agency (HHA) and Power Mobility Devices.
What is PECOS?
PECOS is the online Medicare enrollment management system or Provider, Enrollment, Chain and Ownership System. The PECOS system is a database of providers who have registered with CMS as providers or suppliers. PECOS is the primary source of information about verified Medicare professionals. Providers that want to participate in this program need to enroll in PECOS with their NPI number to avoid denied claims.
Is the provider registered in PECOS? Yes
Eligible to Order or Refer Part B Clinical Laboratory and Imaging: Yes
Eligible to Order or Refer Durable Medical Equipment (DMEPOS): Yes
Eligible to Order or Refer a Home Health Agency (HHA): Yes
Eligible to Order or Refer Power Mobility Devices: Yes
Provider Referred Orders for Durable Medical Equipment, Devices & Supplies
The following list reflects the services, supplies or durable medical equipment ordered by this provider to a DME supplier on behalf of patients. The information below is derived from Medicare claims data and reflects the BETOS category, HCPCS code information and the number times each service was submitted under the Medicare fee-for-service program.
Unknown
Treatment-Treatment - Miscellaneous (RX029N)
Capecitabine, oral, 500 mg (HCPCS:J8521)
3 DME suppliers used 19 Medicare Claims 1052 Services Paid
Treatment-Chemotherapy (RH012N)
Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period (HCPCS:Q0511)
4 DME suppliers used 14 Medicare Claims 14 Services Paid
Treatment-Chemotherapy (RH012N)
Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period (HCPCS:Q0512)
3 DME suppliers used 11 Medicare Claims 11 Services Paid
Areas of Expertise
The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.
Administration of additional new drug or substance into vein, 1 hour or less
Administration of chemotherapy into vein, 1 hour or less
Administration of chemotherapy into vein, each additional hour
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
Ct scan of abdomen and pelvis with contrast
Ct scan of abdomen and pelvis without contrast
Ct scan of chest with contrast
Ct scan of chest without contrast
Established patient office or other outpatient visit, 20-29 minutes
Established patient office or other outpatient visit, 30-39 minutes
Flow cytometry technique for dna or cell analysis, each additional marker
Flow cytometry technique for dna or cell analysis, first marker
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
Injection of additional new drug or substance into vein
Injection of drug or substance under skin or into muscle
Injection, denosumab, 1 mg
Injection, dexamethasone sodium phosphate, 1 mg
Injection, diphenhydramine hcl, up to 50 mg
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
Injection, fosaprepitant, 1 mg
Injection, gadoterate meglumine, 0.1 ml
Injection, palonosetron hcl, 25 mcg
Injection, pembrolizumab, 1 mg
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
Mri scan of abdomen before and after contrast
Mri scan of brain before and after contrast
New patient office or other outpatient visit, 45-59 minutes
Nuclear medicine study from skull base to mid-thigh with ct scan
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
Telephone medical discussion with physician, 11-20 minutes
This procedure involves introducing a new drug or substance into your vein, typically via an IV drip. It lasts for an hour or less. This method allows the substance to quickly reach your bloodstream, ensuring rapid and effective treatment.
This service was performed 134 times for 15 patientsChemotherapy is a treatment that uses drugs to destroy cancer cells. When administered into a vein, it's often through an IV. This procedure usually lasts 1 hour or less. You may feel a slight pinch as the needle is inserted, but it's generally painless.
This service was performed 467 times for 58 patientsChemotherapy is a treatment method that uses drugs to destroy cancer cells. The drugs are administered into a vein, usually in the arm. Each additional hour of chemotherapy allows for more of the medication to enter your bloodstream to fight against the cancer cells.
This service was performed 375 times for 34 patientsThis procedure involves the injection of hormone-based anti-cancer drugs under the skin or into a muscle. These medications help to slow down or stop the growth of certain types of cancer cells. The process is usually quick and can be performed in a clinic or hospital.
This service was performed 57 times for 14 patientsA CT scan of the abdomen and pelvis with contrast is an imaging procedure. A special dye, called contrast, is used to make certain areas more visible. This can help identify issues such as infections, tumors, or other abnormalities. The procedure is painless and usually takes about 30 minutes.
This service was performed 88 times for 72 patientsA CT scan of the abdomen and pelvis is a non-invasive medical test. It uses special X-ray equipment to create detailed images of your abdominal and pelvic areas. This helps doctors examine organs, tissues, and vessels. No contrast dye is used in this procedure.
This service was performed 29 times for 20 patientsA CT scan of the chest with contrast is an imaging procedure. A special dye (contrast) is used to highlight specific areas in your body, providing clearer pictures of your chest. This helps in diagnosing conditions related to your lungs, heart, and other chest structures.
This service was performed 83 times for 63 patientsA CT scan of the chest without contrast is a non-invasive imaging procedure. It uses special X-ray equipment to produce detailed images of your chest area, including your lungs and heart. It can help diagnose conditions such as lung diseases or heart disorders. It doesn't involve any dyes or contrast agents.
This service was performed 34 times for 22 patientsThis is a routine visit for patients who have already been seen by the healthcare provider. During this approximately 20-29 minute appointment, your health status will be evaluated and any necessary treatments or tests will be discussed. It's a chance to address any health concerns you may have.
This service was performed 451 times for 297 patientsThis is a routine check-up for patients who have previously visited our clinic. It involves a comprehensive review of your health and any ongoing treatments. The consultation lasts between 30-39 minutes, allowing enough time to discuss any concerns.
This service was performed 799 times for 277 patientsFlow cytometry is a technique that helps analyze the physical and chemical characteristics of cells or particles. When an additional marker is used, it aids in identifying specific cell types or stages of disease. This helps in precise diagnosis and treatment planning.
This service was performed 1,639 times for 46 patientsFlow cytometry is a technique used to examine microscopic particles, like cells or DNA. It employs a beam of light to detect and measure physical and chemical characteristics of these particles. The 'first marker' refers to a specific characteristic or feature used to identify a particular cell or particle.
This service was performed 71 times for 46 patientsFluorodeoxyglucose F-18 FDG is a radioactive drug used in PET scans. It helps doctors see how your tissues and organs are functioning. The drug is given in a specific dose, up to 45 millicuries, depending on your body size and the type of scan.
This service was performed 92 times for 67 patientsThis is a procedure where a medical professional inserts a small tube into your vein to deliver medication, nutrients, or fluids directly into your bloodstream. This can be for treatment, prevention, or diagnosis. The process typically takes less than an hour.
This service was performed 138 times for 53 patientsThis procedure involves injecting fluids or medication directly into your vein. It's used for treatment, prevention, or diagnosis. An additional sequential infusion may be given within an hour if needed. This helps to ensure the medicine is distributed effectively in your body.
This service was performed 801 times for 82 patientsThis procedure involves introducing a new medication or substance into your bloodstream via a vein. It's typically done using a small needle. The substance can help treat various conditions or assist in diagnostic procedures. It's generally safe and monitored by professionals.
This service was performed 21 times for 14 patientsThis procedure involves administering medication directly under the skin or into a muscle. A small needle is used to inject the drug, allowing it to be absorbed quickly into the bloodstream. It's a common method for delivering a variety of medications.
This service was performed 159 times for 40 patientsDenosumab is a medication given via injection to strengthen your bones. It works by slowing down the cells that break down bone, improving bone density and reducing the risk of fractures. It's often used for osteoporosis treatment.
This service was performed 6,060 times for 23 patientsDexamethasone sodium phosphate is a medication given via injection. It is a type of steroid that helps reduce inflammation and immune responses. It can be used to treat a variety of conditions, such as allergies, skin conditions, arthritis, and more.
This service was performed 3,331 times for 65 patientsDiphenhydramine HCL injection is a medicine given to alleviate symptoms of allergies, colds, or hay fever. It can also help with motion sickness and certain symptoms of Parkinson's disease. Up to 50 mg may be administered depending on your condition.
This service was performed 192 times for 32 patientsFerumoxytol injection is a treatment for iron deficiency anemia, a condition where your body lacks enough iron. It is injected into your vein to increase iron levels, aiding in the production of healthy red blood cells. This treatment is not for ESRD patients.
This service was performed 51,000 times for 39 patientsFosaprepitant is an anti-nausea medication given via injection. It's often used to prevent nausea and vomiting caused by chemotherapy. This injection blocks signals to the brain that trigger these symptoms, helping you feel better.
This service was performed 11,101 times for 13 patientsGadoterate meglumine is a contrast agent used in MRI scans to help visualize certain areas of your body more clearly. It's injected into your bloodstream, typically through a vein in your arm, and helps doctors get more detailed images.
This service was performed 8,450 times for 40 patientsPalonosetron HCL is an injection used to prevent nausea and vomiting caused by chemotherapy. It works by blocking a natural substance (serotonin) in the body that can cause vomiting. This helps improve your comfort during cancer treatment.
This service was performed 1,081 times for 17 patientsPembrolizumab is a medication given via injection to help your body's immune system fight certain types of cancer. It's typically administered in a hospital or clinic by a healthcare professional.
This service was performed 22,800 times for 13 patientsLow osmolar contrast material with 300-399 mg/ml iodine concentration is a diagnostic tool used in imaging procedures. It helps to enhance the visibility of specific areas in the body, aiding in accurate diagnosis. It's safe and generally well-tolerated by patients.
This service was performed 14,500 times for 107 patientsAn MRI scan of the abdomen before and after contrast provides detailed images of your abdominal organs. Initially, images are taken without a contrast agent. Then, a safe dye is administered, usually via an IV, to highlight certain areas, giving a clearer picture to help diagnose various conditions.
This service was performed 23 times for 18 patientsAn MRI scan of the brain, both before and after contrast, helps visualize different brain structures. Initially, images are taken without a contrast agent. Then, a safe dye is injected which helps highlight certain areas, providing clearer, more detailed images.
This service was performed 18 times for 16 patientsThis is a first-time office or outpatient visit lasting between 45-59 minutes. The healthcare provider evaluates your health, discusses your medical history, and may suggest further tests or treatments. It's an opportunity to ask questions and understand your health better.
This service was performed 46 times for 46 patientsA nuclear medicine study from skull base to mid-thigh with a CT scan involves using a small amount of radioactive material and CT imaging to examine body tissues and organs. This helps detect any abnormalities by providing detailed images of the body's internal structure.
This service was performed 102 times for 74 patientsThe Oncology Care Model (OCM) Monthly Enhanced Oncology Services (MEOS) payment, denoted by G9678, is a compensation method for OCM practitioners. These payments are specifically for providing additional, or "enhanced", services to OCM beneficiaries, as outlined in the OCM participation agreement.
This service was performed 147 times for 54 patientsThis is a service where you have a phone conversation with your doctor for 11-20 minutes. It's used for discussing health concerns, reviewing test results, or managing ongoing conditions. It's a convenient way to receive medical advice without an in-person visit.
This service was performed 26 times for 22 patientsPhysician Visit Costs
The pricing information below displays the copayment minimum, maximum and average amount that patients under Medicare are charged when visiting this provider as a new or established patient. Please keep in mind that these prices are just for reference purposes, and the actual prices charged by the provider might be different.
For patients covered under private health plans the prices below are also useful as healthcare pricing for private insurance is usually established as a function of Medicare prices. Private insurance covered patients should check their individual plans to determine the exact pricing.
The prices below reflect the costs for new and established patients in the 77339 ZIP code area.
New Patients Visit Costs *
The most utilized procedure code for new patients office visits is 99205
- Average New Patient Price $176.98
- Minimum New Patient Price $58.24
- Maximum New Patient Price $176.98
- Average New Patient Copayment $44.24
- Minimum New Patient Copayment $14.56
- Maximum New Patient Copayment $44.24
Established Patients Visit Costs *
The most utilized procedure code for established patients office visits is 99214
- Average Established Patient Price $102.71
- Minimum Established Patient Price $18.6
- Maximum Established Patient Price $143.93
- Average Established Patient Copayment $25.67
- Minimum Established Patient Copayment $4.65
- Maximum Established Patient Copayment $35.98
* The physician office visit costs information is generated by statistical analysis of similar providers in the same geographical area. The pricing information above IS NOT the amount charged by this provider.
Quality Reporting
The provider participated in CMS Quality Payment Program. The Quality Payment Program aims to improve population health, reduce costs and improve the care received by Medicare beneficiaries. The following quality measures meet Medicare's statistical reporting standards. Not all providers report the same information, because not all providers give the same services to patients. The quality information is just a snapshot of some the care providers give to their patients. Reporting more or less information is not a reflection of quality.
| Quality Measure | Performance | Number of Patients |
|---|---|---|
| Anticoagulant Management Improvements | Yes | N/A |
| Individual MIPS eligible clinicians and groups who prescribe oral Vitamin K antagonist therapy (warfarin) must attest that, for 60 percent of practice patients in the transition year and 75 percent of practice patients in Quality Payment Program Year 2 and future years, their ambulatory care patients receiving warfarin are being managed by one or more of the following improvement activities: • Patients are being managed by an anticoagulant management service, that involves systematic and coordinated care, incorporating comprehensive patient education, systematic prothrombin time (PT-INR) testing, tracking, follow-up, and patient communication of results and dosing decisions; • Patients are being managed according to validated electronic decision support and clinical management tools that involve systematic and coordinated care, incorporating comprehensive patient education, systematic PT-INR testing, tracking, follow-up, and patient communication of results and dosing decisions; • For rural or remote patients, patients are managed using remote monitoring or telehealth options that involve systematic and coordinated care, incorporating comprehensive patient education, systematic PT-INR testing, tracking, follow-up, and patient communication of results and dosing decisions; and/or • For patients who demonstrate motivation, competency, and adherence, patients are managed using either a patient self-testing (PST) or patient-self-management (PSM) program. | ||
| Care Plan | 88% | 597 |
| Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record that an advance care plan was discussed but the patient did not wish or was not able to name a surrogate decision maker or provide an advance care plan | ||
| Depression screening | Yes | N/A |
| Depression screening and follow-up plan: Regular engagement of MIPS eligible clinicians or groups in integrated prevention and treatment interventions, including depression screening and follow-up plan (refer to NQF #0418) for patients with co-occurring conditions of behavioral or mental health conditions. | ||
| Documentation of Current Medications in the Medical Record | 100% | 5271 |
| Percentage of visits for patients aged 18 years and older for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter. This list must include ALL known prescriptions, over-the-counters, herbals, and vitamin/mineral/dietary (nutritional) supplements AND must contain the medications' name, dosage, frequency and route of administration | ||
| e-Prescribing | 43% | 791 |
| At least one permissible prescription written by the MIPS eligible clinician is queried for a drug formulary and transmitted electronically using certified EHR technology. | ||
| Immunization Registry Reporting | Yes | N/A |
| The MIPS eligible clinician is in active engagement with a public health agency to submit immunization data. | ||
| Medication Reconciliation | 100% | 400 |
| The MIPS eligible clinician performs medication reconciliation for at least one transition of care in which the patient is transitioned into the care of the MIPS eligible clinician. | ||
| Oncology: Medical and Radiation - Pain Intensity Quantified | 100% | 1918 |
| Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantified | ||
| Oncology: Medical and Radiation - Plan of Care for Pain | 100% | 217 |
| Percentage of visits for patients, regardless of age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy who report having pain with a documented plan of care to address pain | ||
| Pain Assessment and Follow-Up | 100% | 3675 |
| Percentage of visits for patients aged 18 years and older with documentation of a pain assessment using a standardized tool(s) on each visit AND documentation of a follow-up plan when pain is present | ||
| Patient-Specific Education | 100% | 1510 |
| The MIPS eligible clinician must use clinically relevant information from CEHRT to identify patient-specific educational resources and provide access to those materials to at least one unique patient seen by the MIPS eligible clinician. | ||
| Preventive Care and Screening: Screening for Depression and Follow-Up Plan | 48% | 1429 |
| Percentage of patients aged 12 years and older screened for depression on the date of the encounter using an age appropriate standardized depression screening tool AND if positive, a follow-up plan is documented on the date of the positive screen | ||
| Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 90% | 1182 |
| Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received tobacco cessation intervention if identified as a tobacco user | ||
| Provide Patient Access | 63% | 1510 |
| At least one patient seen by the MIPS eligible clinician during the performance period is provided timely access to view online, download, and transmit to a third party their health information subject to the MIPS eligible clinician's discretion to withhold certain information. | ||
| Secure Messaging | 63% | 1510 |
| For at least one unique patient seen by the MIPS eligible clinician during the performance period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient-authorized representative), or in response to a secure message sent by the patient (or the patient-authorized representative) during the performance period. | ||
| Security Risk Analysis | Yes | N/A |
| Conduct or review a security risk analysis in accordance with the requirements in 45 CFR 164.308(a)(1), including addressing the security (to include encryption) of ePHI data created or maintained by certified EHR technology in accordance with requirements in 45 CFR164.312(a)(2)(iv) and 45 CFR 164.306(d)(3), and implement security updates as necessary and correct identified security deficiencies as part of the MIPS eligible clinician's risk management process. | ||
| Tobacco use | Yes | N/A |
| Tobacco use: Regular engagement of MIPS eligible clinicians or groups in integrated prevention and treatment interventions, including tobacco use screening and cessation interventions (refer to NQF #0028) for patients with co-occurring conditions of behavioral or mental health and at risk factors for tobacco dependence. | ||
| Use of High-Risk Medications in the Elderly | 3% "Inverse Quality Measure" This is an inverse quality measure, a lower rate means the provider is rated better. | 684 |
| Percentage of patients 65 years of age and older who were ordered high-risk medications. Two rates are submitted. 1) Percentage of patients who were ordered at least one high-risk medication. 2) Percentage of patients who were ordered at least two of the same high-risk medication | ||
Reviews for GREGORY T SEYMOUR MD
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI Validation Check Digit Calculation
The following table explains the step by step NPI number validation process using the ISO standard Luhn algorithm.
| Start with the original NPI number, the last digit is the check digit and is not used in the calculation. | |||||||||
| 1 | 7 | 2 | 0 | 0 | 4 | 1 | 0 | 5 | 6 |
| Step 1: Double the value of the alternate digits, beginning with the rightmost digit. | |||||||||
| 2 | 7 | 4 | 0 | 0 | 4 | 2 | 0 | 10 | |
| Step 2: Add all the doubled and unaffected individual digits from step 1 plus the constant number 24. | |||||||||
| 2 + 7 + 4 + 0 + 0 + 4 + 2 + 0 + 1 + 0 + 24 = 44 | |||||||||
| Step 3: Subtract the total obtained in step 2 from the next higher number ending in zero, the result is the check digit. | |||||||||
| 50 - 44 = 6 | 6 | ||||||||
The NPI number 1720041056 is valid because the calculated check digit 6 using the Luhn validation algorithm matches the last digit of the original NPI number.
Other Providers at the Same Location
The following 15 providers are registered at the same or nearby location.
| NPI | Name / Type | Taxonomy | Address |
|---|---|---|---|
| 1386625002 | DR. ERNEST J MENDOZA MD Individual | Family Medicine | 22710 PROFESSIONAL DR SUITE 202 KINGWOOD, TX 77339 (281) 312-8521 |
| 1811950140 | CARMEN JOSEFA PEREZ MD Individual | Internal Medicine | 22710 PROFESSIONAL DR SUITE 203 KINGWOOD, TX 77339 (281) 312-8531 |
| 1033141569 | NIMI L TUAMOKUMO M.D. Individual | Radiology (Radiation Oncology) | 22710 PROFESSIONAL DR RADIATION DEPARTMENT KINGWOOD, TX 77339 (281) 312-8545 |
| 1972670032 | HAZEL J HEDDINGS MD Individual | Family Medicine | 22710 PROFESSIONAL DR KINGWOOD, TX 77339 (281) 312-8570 |
| 1467675454 | VANESSA LYNN ELLEDGE P.A.-C Individual | Physician Assistant | 22710 PROFESSIONAL DR SUITE 202 KINGWOOD, TX 77339 (281) 312-8521 |
| 1710231261 | SHANNON MARIE JOHNSON NP-C Individual | Nurse Practitioner (Adult Health) | 22710 PROFESSIONAL DR SUITE 201 KINGWOOD, TX 77339 (281) 312-8510 |
| 1114335775 | MILLENNIUM PHYSICIANS ASSOCIATON, PLLC Organization | Nurse Practitioner (Family) | 22710 PROFESSIONAL DR SUITE 203 KINGWOOD, TX 77339 (281) 312-8530 |
| 1841298387 | ANIRUDHA DASGUPTA MD Individual | Internal Medicine (Hematology & Oncology) | 22710 PROFESSIONAL DR KINGWOOD, TX 77339 (281) 298-8444 |
| 1548223878 | PIERRE N KHOURY MD Individual | Internal Medicine (Hematology & Oncology) | 22710 PROFESSIONAL DR SUITE 100 KINGWOOD, TX 77339 (281) 298-8444 |
| 1558763060 | MRS. DEANNA MARIE CAMACHO FNP Individual | Nurse Practitioner (Family) | 22710 PROFESSIONAL DR SUITE 203 KINGWOOD, TX 77339 (281) 312-8530 |
| 1730142068 | MURTAZA N BHURIWALA MD Individual | Internal Medicine (Hematology & Oncology) | 22710 PROFESSIONAL DR KINGWOOD, TX 77339 (281) 298-8444 |
| 1740732932 | MRS. GAYLE GORDON FNP Individual | Nurse Practitioner (Family) | 22710 PROFESSIONAL DR SUITE 203 KINGWOOD, TX 77339 (281) 312-8530 |
| 1639132962 | SAMER S SUKI MD Individual | Internal Medicine (Hematology & Oncology) | 22710 PROFESSIONAL DR KINGWOOD, TX 77339 (281) 298-8444 |
| 1801851225 | SALVADOR RAFAEL RECIO MD Individual | Internal Medicine | 22710 PROFESSIONAL DR SUITE 203 KINGWOOD, TX 77339 (281) 312-8530 |
| 1164425211 | DR. MARY K CROW M.D. Individual | Internal Medicine (Hematology & Oncology) | 22710 PROFESSIONAL DR KINGWOOD, TX 77339 (281) 298-8444 |
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1720041056, enumerated in the NPI registry as an "individual" on April 08, 2006
The provider is located at 22710 Professional Dr Kingwood, Tx 77339 and the phone number is (281) 298-8444
The provider's speciality is Internal Medicine with taxonomy code 207RH0003X with a focus in Hematology & Oncology
The provider might be accepting Accepts: Blue Cross and Blue Shield of Texas, Medicare and. Please consult your insurance carrier or call the provider to make sure your health plan is currently accepted.
Yes, as of June 20, 2025 the provider is registered in PECOS and is eligible to order health care services or supplies for Medicare patients. If you are a beneficiary the provider is eligible to order or refer: Part B Clinical Laboratory and Imaging, Durable Medical Equipment (DME), a Home Health Agency (HHA) and Power Mobility Devices.
Medicare beneficiaries should expect a typical cost of $176.98 with an average copayment of $44.24 for new patient appointments. Established patients should expect a typical charge of $102.71 and an average copayment of 25.67. Please review your insurance plan or contact the provider directly to determine your specific costs.
The most common procedures or services performed by this practitioner are: Administration of additional new drug or substance into vein, 1 hour or less, Administration of chemotherapy into vein, 1 hour or less, Administration of chemotherapy into vein, each additional hour, Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle, Ct scan of abdomen and pelvis with contrast, Ct scan of abdomen and pelvis without contrast, Ct scan of chest with contrast, Ct scan of chest without contrast, Established patient office or other outpatient visit, 20-29 minutes, Established patient office or other outpatient visit, 30-39 minutes, Flow cytometry technique for dna or cell analysis, each additional marker, Flow cytometry technique for dna or cell analysis, first marker, Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries, Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less, Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less, Injection of additional new drug or substance into vein, Injection of drug or substance under skin or into muscle, Injection, denosumab, 1 mg, Injection, dexamethasone sodium phosphate, 1 mg, Injection, diphenhydramine hcl, up to 50 mg, Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use), Injection, fosaprepitant, 1 mg, Injection, gadoterate meglumine, 0.1 ml, Injection, palonosetron hcl, 25 mcg, Injection, pembrolizumab, 1 mg, Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml, Mri scan of abdomen before and after contrast, Mri scan of brain before and after contrast, New patient office or other outpatient visit, 45-59 minutes, Nuclear medicine study from skull base to mid-thigh with ct scan, Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a and Telephone medical discussion with physician, 11-20 minutes.
This NPI record was last updated on April 08, 2006. To officially update your NPI information contact the National Plan and Provider Enumeration System (NPPES) at 1-800-465-3203 (NPI Toll-Free) or by email at [email protected].
NPI Profile data is regularly updated with the latest NPI registry information, if you would like to update or remove your NPI Profile in this website please contact us.